DXCM 69.55 (-0.5%)
US2521311074Medical Diagnostics & ResearchDiagnostics & Research

DexCom (DXCM) Competitor Comparison

We are evaluating the key criteria listed to compare DexCom (DXCM) against its competitors in the Diagnostics & Research industry.

Linearity 3 years - DXCM ranking 22 / 58

These are the competitors of DexCom in the industry Diagnostics & Research ranked by linearity 3 years
1. Danaher DHR
152.06
2. Mettler-Toledo MTD
80.11
3. Thermo Fisher Scientific TMO
76.37
4. Waters WAT
46.65
5. Quest Diagnostics DGX
44.38
6. Ortho Clinical Diagnostics Holdings OCDX
33.4
7. Agilent Technologies A
29.68
8. Laboratory Corp of America Holdings LH
26.37
9. IQVIA Holdings IQV
23.88
10. Icon ICLR
22.67
11. PerkinElmer PKI
16.14
12. Qiagen QGEN
12.95
13. Syneos Health SYNH
10.68
14. Bioventus BVS
9.92
15. Heska HSKA
7.67
16. IDEXX Laboratories IDXX
7.09
17. Myriad Genetics MYGN
6.81
18. Olink Holding OLK
6.67
19. Anixa Biosciences ANIX
6.32
20. Natera NTRA
5.87
21. Exact Sciences EXAS
5.55
22. DexCom DXCM
4.53
23. Global Cord Blood CO
4.22
24. National Research NRC
4.19
25. Sotera Health SHC
3.99
26. Sera Prognostics SERA
3.46
27. Charles River Laboratories CRL
3.27
28. Neogen NEOG
2.63
29. Psychemedics PMD
2.63
30. Illumina ILMN
2.59
31. MaxCyte MXCT
2.51
32. Enzo Biochem ENZ
2.49
33. Fulgent Genetics FLGT
2.39
34. Trinity Biotech TRIB
2.15
35. Twist Bioscience TWST
2.14
36. Medpace Holdings MEDP
2.1
37. NeoGenomics NEO
2.08
38. MDxHealth MDXH
2.05
39. Guardant Health GH
2.04
40. Neuronetics STIM
1.98
41. CareDx CDNA
1.98
42. Co-Diagnostics CODX
1.89
43. Exagen XGN
1.82
44. bioAffinity Technologies BIAF
1.79
45. DarioHealth DRIO
1.79
46. Organovo Holdings ONVO
1.79
47. Pacific Biosciences of California PACB
1.78
48. Inotiv NOTV
1.76
49. Interpace Biosciences IDXG
1.76
50. Biodesix BDSX
1.73
51. Prenetics Global PRE
1.72
52. Precipio PRPO
1.69
53. Personalis PSNL
1.57
54. SeqLL SQL
1.48
55. Aspira Womens Health AWH
1.38
56. Meridian Bioscience VIVO
0.73
57. RadNet RDNT
0.65
58. Lantheus Holdings LNTH
0.58

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.